# Efficacy of Varenicline in Ambivalent Smokers

> **NCT00595868** · PHASE2 · COMPLETED · sponsor: **University of Vermont Medical Center** · enrollment: 220 (actual)

## Conditions studied

- Tobacco Use Disorder
- Tobacco Use Cessation
- Nicotine Dependence

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00595868
- **Lead sponsor:** University of Vermont Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2011-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595868, "Efficacy of Varenicline in Ambivalent Smokers". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT00595868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*